A clinical trial on Rashnadi Chooranam in the management of kumbavatham (Periarthritis) among patients attending OPD and IPD of Government Siddha Medical College and Hospital Palayamkottai

A prospective open labelled single arm non-randomized single centric phase II clinical trial to determine the effectiveness of Rashnadi Chooranam in the management of Kumbavatham(Periarthritis) - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085897

Enrollment

Registered

2025-04-29

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M750- Adhesive capsulitis of shoulder

Interventions

Intervention1: RASHNADI CHOORANAM: 2 g twice a day after food orally with hot water for 45 days Control Intervention1: Nil: Nil Control Intervention2: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Patient having main symptoms of shoulder joint pain, numbness ,wasting in the shoulder region and arms, restricted movement of the upper limbs, loss of abduction &forward flexion, stiffness of the shoulder joint. Diabetes mellitus

Exclusion criteria

Exclusion criteria: Age: below 29 to above 61 years Rheumatoid arthritis Ischaemic heart diseases Pregnancy and lactating mother Recent shoulders dislocation. Recent shoulder fracture

Design outcomes

Primary

Measure	Time frame
The outcome will be aimed at reducing the symptoms of Kumbavatham(Periarthritis)and to determine the therapeutic efficacy of clinical trials drug(Rashnadi chooranam)Timepoint: 45 days	—

Secondary

Measure	Time frame
Evaluation of additional effects and siddha parameters changes in kumba vatham Timepoint: 6 months	—

Countries

India

Contacts

Public ContactDr S UMA KALYANI

Government Siddha Medical College and Hospital,Palayamkottai

sukgsmc2014@gmail.com8072685509

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026